Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine for bipolar depression: randomized placebo-controlled and open-label extension
jRCTs031240400Recruiting
- Sponsor
- Takeda Science Foundation
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ketamine in bipolar disorder (BD) (3 arms), sponsored by Takeda Science Foundation. Started Feb 2025; status: recruiting.
02
Drugs
ketamine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on jRCTs031240400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240400.